Mechanism of paclitaxel activity in Kaposi's sarcoma

Journal of Immunology

Volumn 165, Issue 1, 2000, Pages 509-517

  Sgadari, Cecilia ^a   Toschi, Elena ^a   Palladino, Clelia ^a   Barillari, Giovanni ^a   Carlei, Davide ^a   Cereseto, Anna ^a   Ciccolella, Cristiana ^a   Yarchoan, Robert ^b   Monini, Paolo ^a   Stürzl, Michael ^c   Ensoli, Barbara ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b NATIONAL CANCER INSTITUTE   (United States)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PACLITAXEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CELL VIABILITY; DRUG MECHANISM; KAPOSI SARCOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTO ONCOGENE; SPINDLE CELL;

EID: 0034235226     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.1.509     Document Type: Article

References (78)

1. Ensoli, B., and M. Stürzl. 1998. Kaposi's sarcoma: a result of the interplay among inflammatory cytokines, angiogenic factors and viral agents. Cytokine Growth Factor Rev. 9:63.
2. Ensoli, B., S. Nakamura, S. Z. Salahuddin, P. Biberfeld, L. Larsson, B. Beaver, F. Wong-Staal, and R. C. Gallo. 1989. AIDS-Kaposi's sarcoma-derived cells express cytokines with autocrine and paracrine growth effects. Science 243:223.
3. Ensoli, B., R. Gendelman, P. Markham, V. Fiorelli, S. Colombini, M. Raffeld, A. Cafaro, H. K. Chang, J. N. Brady, and R. C. Gallo. 1994. Synergy between basic fibroblast growth factor and HIV-1 Tat protein in induction of Kaposi's sarcoma development. Nature 371:674.
4. Ensoli, B., P. Markham, V. Kao, G. Barillari, V. Fiorelli, R. Gendelman, M. Raffeld, G. Zon, and R. C. Gallo. 1994. Block of AIDS-Kaposi's sarcoma (KS) cell growth, angiogenesis and lesion formation in nude mice by antisense oligonucleotide targeting basic fibroblast growth factor: a novel strategy for the therapy of KS. J. Clin. Invest. 94:1736.
5. Barillari, G., L. Buonaguro, V. Fiorelli, J. Hoffman, F. Michaels, R. C. Gallo, and B. Ensoli, 1992. Effects of cytokines from activated immune cells on vascular cell growth and HIV-1 gene expression: implications for AIDS-Kaposi's sarcoma pathogenesis. J. Immunol. 149:3727.
6. Fiorelli, V., R. Gendelman, F. Samaniego, P. D. Markham, and B. Ensoli. 1995. Cytokines from activated T cells induce normal endothelial cells to acquire the phenotypic and functional features of AIDS-Kaposi's sarcoma spindle cells. J. Clin. Invest. 95:1723.
7. + T cells infiltrating Kaposi's sarcoma induces spindle cells with angiogenic phenotype and synergy with HIV-1 Tat protein: an immune response to HHV-8 infection? Blood 91:956.
8. Samaniego, F., P. Markham, R. C. Gallo, and B. Ensoli, 1995. Inflammatory cytokines induce AIDS-Kaposi's sarcoma-derived spindle cells to produce and release basic fibroblast growth factor and enhance Kaposi's sarcoma-like lesion formation in nude mice. J. Immunol. 154:3582.
9. Samaniego, F., P. D. Markham, R. Gendelman, R. C. Gallo, and B. Ensoli. 1997. Inflammatory cytokines induce endothelial cells to produce and release basic fibroblast growth factor and to promote Kaposi's sarcoma-like lesions in nude mice. J. Immunol. 158:1887.
10. Samaniego, F., P. D. Markham, R. Gendelman, Y. Watanabe, V. Kao, K. Kowalsky, J. A. Sonnabend, A. Pintus, R. C. Gallo, and B. Ensoli. 1998. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma are induced by inflammatory cytokines and synergize to induce vascular permeability and KS lesion development. Am. J. Pathol. 152: 1433.
11. Cornali, E., C. Zietz, R. Benelli, W. Weninger, L. Masiello, G. Breier, E. Tschachler, A. Albini, and M. Stürzl. 1996. Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma. Am. J. Pathol. 149:1851.
12. Chang, Y., E. Cesarman, M. S. Pessin, F. Lee, J. Culpepper, D. M. Knowles, and P. S. Moore. 1994. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865.
13. Moore, P. S., and Y. Chang. 1995. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N. Engl. J. Med. 332:1181.
14. de Lellis, L., M. Fabris, F. Cassai, A. Corallini, G. Giraldo, C. Feo, and P. Monini. 1995. Herpes-virus-like DNA sequences in non-AIDS Kaposi's sarcoma. J. Infect. Dis. 177:1605.
15. Schalling, M., M. Ekman, E. E. Kaaya, A. Linde, and P. Biberfeld. 1995. A role for a new herpesvirus (KSHV) in different forms of Kaposi's sarcoma. Nat. Med. 1:707.
16. Huang, Y. Q., J. J. Li, M. H. Kaplan, B. Poiesz, E. Katabira, W. C. Zhang, D. Feiner, and A. E. Friedman-Kien. 1995. Human herpesvirus-like nucleic acid in various forms of Kaposi's sarcoma. Lancet 345:759.
17. Monini, P., S. Colombini, M. Stürzl, D. Goletti, A. Cafaro, C. Sgadari, S. Buttò, M. Franco, P. Leone, S. Fais, et al. 1999. Reactivation and persistence of human herpesvirus-8 infection in B cells and monocytes by Th-1 cytokines increased in Kaposi's sarcoma. Blood 93:4044.
18. Sirianni, M. C., L. Vincenzi, V. Fiorelli, S. Topino, E. Scala, S. Uccini, A. Angeloni, A. Faggioni, D. Cerimele, F. Cottoni, et al. 1998. γ-Interferon production in peripheral blood mononuclear cells (PBMC) and tumour infiltrating lymphocytes from Kaposi's sarcoma patients: correlation with the presence of human herpesvirus-8 in PBMC and lesional macrophages. Blood 91:968.
19. Ensoli, B., G. Barillari, S. Z. Salahuddin, R. C. Gallo, and F. Wong-Staal. 1990. Tat protein of HIV-1 stimulates the growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 345:84.
20. Barillari, G., R. Gendelman, R. C. Gallo, and B. Ensoli. 1993. The Tat protein of human immunodeficiency virus type I, a growth factor for AIDS Kaposi's sarcoma and cytokine-activated vascular cells, induces adhesion of the same cell types by using integrin receptors recognizirg the RGD amino acid sequence. Proc. Natl. Acad. Sci. USA 90:7941.
21. 3 integrin that are required for Tat activity. J. Immunol. 162:1165.
22. 3 integrins by mobilizing sequestered basic fibroblast growth factor. Blood 94:663.
23. Real, F., and S. E. Krown. 1985. Spontaneous regression of Kaposi's sarcoma in patients with AIDS. N. Engl. J. Med. 313:1659.
24. Brooks, J. J. 1986. Kaposi's sarcoma: a reversible hyperplasia. Lancet 2:1309.
25. Saikevyc, I. A., M. Mayer, R. L. White, and R. C. Ho. 1988. Cytogenetic study of Kaposi's sarcoma associated with acquired immunodeficiency syndrome. Arch. Pathol. Lab. Med. 112:825.
26. Dictor, M., M. Ferno, and B. Baldentorp. 1991. Flow cytometric DNA content in Kaposis's sarcoma by histologic stage: comparison with angiosarcoma. Anal. Quant. Cytol. Histol. 13:201.
27. Rabkin, C. S., G. Bedi, E. Musaba, R. Sunkutu, N. Mwansa, D. Sidransky, and R. Biggar. 1995. AIDS-related Kaposi's Sarcoma is a clonal neoplasm. Clin. Cancer Res. 1:257.
28. Rabkin, C. S., S. Janz, A. Lash, A. E. Coleman, E. Musaba, L. Liotta, R. J. Biggar, and Z. Zhuang. 1997. Monoclonal origin of multicentric Kaposi's sarcoma lesions. N. Engl. J. Med. 336:988.
29. Bohan-Morris, C., R. Gendelman, A. J. Marrogi, M. Lu, J. M. Lockyer, W. Alperin-Lea, and B. Ensoli. 1996. Immunohistochemical detection of Bcl-2 in AIDS-associated and classical Kaposi's sarcoma. Am. J. Pathol. 148:1055.
30. Montmayeur, F., V. Krajewski, F. Bejui-Thivolet, D. Schlaifer, G. Delsol, J. C. Reed, and P. Brousset. 1997. In vivo patterns of apoptosis-regulating protein expression in Kaposi's sarcoma. Appl. Immunohistochem. 5:104.
31. Hockenberry, D., G. Nunez, C. Milliman, R. D. Schreiber, and S. J. Korsmeyer. 1990. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334.
32. Nunez, G., L. London, D. Hockenberry, M. Alexander, J. P. McKean, and S. J. Korsmeyer. 1990. Deregulated Bcl-2 gene expression selectively prolongs survival of growth factor-deprived homopoietic cell lines. J. Immunol. 9:3502.
33. Stürzl, M., A. Wunderlich, G. Ascherl, C. Zietz, C. Hohenadl, E. Castanos-Velez, P. Monini, P. Kellam, P. Biberfeld, P. Browning, and B. Ensoli. 1999. Expression of the K13/vFLIP gene of human herpesvirus-8 in Kaposi's sarcoma and lymph node tissues correlates with reduction of apoptosis. J. Natl. Cancer Inst. 91:1725.
34. Rowinsky, E. K. 1997. Paclitaxel pharmacology and other tumor types. Semin. Oncol. 24.-S19-1.
35. Saville, M. W., J. Lietzau, J. M. Pluda, I. Feuerstein, J. Odom, W. H. Wilson, R. W. Humphrey, E. Feigel, S. M. Steinberg, S. Broder, and R. Yarchoan. 1995. Treatment of HIV-associated Kaposi's sarcoma with paclitaxel. Lancet 346:26.
36. Welles, L., M. W. Saville, J. Lietzau, J. M. Pluda, K. M. Wyvill, I. Feuerstein, W. D. Figg, R. Lush, J. Odom, W. H. Wilson, et al. 1998. Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma. J. Clin. Oncol. 16:1112.
37. Von Roenn, J. H., and S. E. Krown. 1998. Management of AIDS-associated Kaposi's sarcoma: a multidisciplinary perspective. Oncology 2:1.
38. McGarvey, M. E., A. Tulpule, J. Cai, T. Zheng, R. Masood, B. Espina, N. Arora, D. L. Smith, and P. S. Gill. 1998. Emerging treatmenl for epidemic (AIDS-related) Kaposis's sarcoma. Curr. Opin. Oncol. 5:413.
39. Gottlieb, J. J., K. Washenik, A. Chachoua, and A. Friedman-Kien. 1997. Treatment of classic Kaposi's sarcoma with liposomal encapsulated doxorubicin. Lancet 350:1363.
40. Northfelt, D. W., B. J. Dezube, J. A. Thommes, B. J. Miller, M. A. Fischl. A. Friedman-Kien, L. D. Kaplan, C. Du Mond, R. D. Mamelok, and D. K. Henry. 1998. Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial. J. Clin. Oncol. 16:2445.
41. Haldar, S., N. Jena, and C. M. Croce. Inactivation of Bcl-2 by phosphorylation. Proc. Natl. Acad. Sci. USA 92:4507.
42. Haldar, S., J. Chintapalli, and C. M. Croce. 1996. Taxol induces Bcl-2 phosphorylation and death of prostate cancer cells. Cancer Res. 56:1253.
43. Haldar, S., A. Basu, and C. M. Croce. 1997. Blc-2 is the guardian of microtubule integrity. Cancer Res. 57:229.
44. Blagosklonny, M. V., T. Schulte, P. Nguyen, J. Trepel, and L. M. Neckers. 1996. Taxol-induced apoptosis and phosphorylation of Bcl-2 protein involves c-Raf-1 signal transduction pathway. Cancer Res. 56:1851.
45. Srivastava, R. K., A. R. Srivastava, S. J. Korsmeyer, M. Nesterova, Y. S. Cho-Chung, and D. L. Longo. 1998. Involvement of microtubules in the regulation of Bcl-2 phosphorylation and apoptosis through cyclic AMP-dependent protein kinase. Mol. Cell. Biol. 18:3509.
46. Bhalla, K., A. M. Ibrado, S. Ray, Y. Huang, C. Tang, A. Nawabi, and R. Hoffman. 1995. p1XY321 protects against Ara-C or taxol-induced apoptosis and loss of clonogenic survival of normal human bone marrow progenitor cells. Leukemia 9:1851.
47. L, and Bax correlate with p53 status and sensitivity to apoptosis in childhood acute lymphoblastic leukemia. Blood 88:2986.
48. 3 induces NB4 cell apoptosis with down-regulation of Bcl-2 expression and modulation of PML-RARα/PML proteins. Blood 88:1052.
49. König, A., L. Wrazel, R. P. Warrell, Jr., R. Rivi, P. P. Pandolfi, A. Jakubowski, and J. L. Gabrilove. 1997. Comparative activity of melarsoprol and arsenic trioxide in chronic B-cell leukemia lines. Blood 90:562.
50. Ziegler, A., G. H. Luedke, D. Fabbro, K. H. Altmann, W. A. Stahel, and U. Zangemeister-Wittke. 1997. Induction of apoptosis in small-cell lung cancer cells by an antisense oligodeoxynucleotide targeting the Bcl-2 coding sequence. J. Natl. Cancer Inst. 89:1027.
51. Reed, J. C., C. Stein, C. Subasinghe, S. Haldar, C. M. Croce, S. Yum, and J. Cohen. 1990. Antisense-mediated inhibition of Bcl2 protooncogene expression and leukemic cell growth and survival: comparison of phosphodiester and phosphorothioate oligodeoxynucleotides. Cancer Res. 50:6565.
52. Tormo, M., A. M. Tari, T. J. McDonnell, F. Cabanillas, J. Garcia-Conde, and G. Lopez-Berestein. 1998. Apoptotic induction in transformed follicular lymphoma cells by Bcl-2 downregulation. Leuk. Lymphoma 30:367.
53. Jansen, B., H. Schlagbauer-Wadl, B. D. Brown, R. N. Bryan, A. van Elsas, M. Muller, K. Wollf, H. G. Eichler, and H. Pehamberger. 1998. Bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice. Nat. Med. 4:232.
54. Berchem, G. J., M. Bosseler, L. Y. Sugars, H. J. Voeller, S. Zeitlin, and E. P. Gelmann. 1995. Androgens induce resislance to bcl-2-mediated apoptosis in LNCaP prostate cancer cells. Cancer Res. 55:735.
55. Salahuddin, S. Z., S. Nakamura, P. Biberfeld, M. H. Kaplan, P. D. Markham, L. Larsson, and R. C. Gallo. 1988. Angiogenic properties of Kaposi's sarcoma-derived cells after long-term culture in vitro. Science 242:430.
56. Nakamura, S., S. Z. Salahuddin, P. Biberfeld, B. Ensoli, P. D. Markham, F. Wong-Staal, and R. C. Gallo. 1988. Kaposi's sarcoma cells: long-term culture with growth factor from retrovirus-infected CD4 T cells. Science 242: 426.
57. Ensoli, B., G. Barillari, S. Z. Salahuddin, R. C. Gallo, and F. Wong-Staal. 1990. Tat protein of HIV-1 stimulates growth of AIDS-Kaposi's sarcoma-derived cells. Nature 345:84.
58. Stürzl, M., C. Blasig, A. Schreier, F. Neipel, C. Hohenadl, E. Cornali, G. Ascherl, S. Esser, N. H. Brockmeyer, M. Ekman, et al. 1997. Expression of HHV-8 latency-associated T0.7 RNA in spindle cells and endothelial cells of AIDS-associated, classical and African Kaposi's sarcoma (KS). Int. J. Cancer 72:68.
59. Albini, A., G. Barillari, R. Benelli, R. C. Gallo, and B. Ensoli. 1995. Angiogenic properties of human immunodeficiency virus type 1 Tat protein. Proc. Natl. Acad. Sci. USA 92:4838.
60. Cheng, E. H. Y., J. Nicholas, D. S. Bellows, G. S. Hayward, H. G. Guo, M. S. Reitz, and J. M. Hardwick. 1997. A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8. inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc. Natl. Acad. Sci. USA 94:690.
61. Kelly, G. D., B. Ensoli, C. J. Gunthel, and M. K. Offermann. 1998. Purified Tat induces inflammatory response genes in Kaposi's sarcoma cells. AIDS 12:1753.
62. Blagosklonny, M. V., P. Giannakakou, W. S. El-Deiry, D. G. I. Kingston, P. I. Higgs, L. Neckers, and T. Fojo. 1997. Raf-1/Bcl-2 phosphorylation: a step from microtubine damage to cell death. Cancer Res. 57:130.
63. Rose, W. C. 1992. Taxol: a review of its preclinical in vivo antitumor activity. Anti-Cancer Drugs 3:311.
64. Kumar, N. 1981. Taxol induced polymerization of purified tubulin: mechanism of action. J. Biol. Chem. 256:10435.
65. Rowinsky, E. K., R. C. Donehower, R. J. Jones, and R. W. Tucker. 1988. Microtubule changes and cytotoxicity in leukemic cell lines treated with Taxol. Cancer Res. 48:4093.
66. Horwitz, S. B. 1992. Mechanism of action of taxol. Trends Pharmacol. Sci. 13:134.
67. Schiff, P. B., and S. B. Horwitz. 1980. Taxol stabilizes microtubules in mouse fibroblast cells. Proc. Natl. Acad. Sci. USA 3:1561.
68. Stearns, M. E., and M. Wang. 1992. Taxol blocks processes essential for prostate tumor cell (PC-3 ML) invasion and metastases. Cancer Res. 52:3776.
69. Belotti, D., V. Vergani, T. Drudis, P. Borsotti, M. R. Pitelli, G. Viale, R. Giavazzi, and G. Taraholetti. 1996. The microtubule-affecting drug paclitaxel has antiangiogenic activity. Clin. Cancer Res. 2:1843.
70. Belotti, D., M. Rieppi, M. I. Nicoletti, A. M. Casazza, T. Fojo, G. Taraboletti, and R. Giavazzi. 1996. Paclitaxel inhibits motility of paclitaxel-resistant human ovarian cancer cell. Clin. Cancer Res. 2:1725.
71. Bhalla, K., A. M. Ibrado, E. Tourkina, C. Tang, M. E. Mahoney, and Y. Huang. 1993. Taxol induces intranucleosomal DNA fragmentation associated with programmed cell death in human myeloid leukemia cells. Leukemia 7:563.
72. Milross, C. G., K. A. Mason, N. R. Hunter, W. K. Chung, L. J. Peters, and L. Milas. 1996. Relationship of mitotic arrest and apoptosis to antitumor effect of paclitaxel. J. Natl. Cancer Inst. 86:1086.
73. Campos, L., O. Sabido, J. P. Rouault, and D. Guyotal. 1994. Effects of Bcl-2 antisense oligodeoxynucleotides on in vitro proliferation and survival of normal marrow progenitors and leukemic cells. Blood 84:595.
74. Teixeira, C., J. C. Reed, and M. A. Pratt. 1995. Estrogen promotes chemotherapeutic drug resistance by a mechanism involving Bcl-2 proto-oncogene expression in human breast cancer cells. Cancer Res. 55:3902.
75. Walker, A., S. T. Taylor, J. A. Hickman, and C. Dive. 1997. Germinal center-derived signals act with Bcl-2 to decrease apoptosis and increase clonogenicity of drug-treated human B lymphoma cells. Cancer Res. 57:1939.
76. Sarid, R., T. Sato, R. A. Bohenzky, J. J. Russo, and Y. Chang. 1997. Kaposi's sarcoma-associated herpesvirus encodes a functional Bcl-2 homologue. Nat. Med. 3:293.
77. Cheng, E. H. Y., J. Nicholas, D. S. Bellows, G. S. Hayward, H. G. Guo, M. S. Reitz, and J. M. Hardwick. 1997. A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc. Natl. Acad. Sci. USA 94:690.
78. Stürzl, M., A. Wunderlich, G. Ascherl, C. Hohenadl, P. Monini, C. Zietz, P. J. Browning, F. Neipel, P. Biberfeld, and B. Ensoli. 1999. Human herpesvirus-8 (HHV-8) gene expression in Kaposi's sarcoma (KS) primary lesions: an in situ hybridization study. Leukemia 13:S110.